[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Multiplex Molecular Diagnostic Market Insights, Forecast to 2029

December 2023 | 92 pages | ID: GF29A2C8D483EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for Multiplex Molecular Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Multiplex Molecular Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Multiplex Molecular Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Multiplex Molecular Diagnostic revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Multiplex Molecular Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Multiplex Molecular Diagnostic revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including BD, bioMйrieux, SpeeDx, Roche, Contextual Genomics, GenMark Diagnostics, Hologic, Luminex Corporation and Binx Health, etc.

By Company
  • BD
  • bioMйrieux
  • SpeeDx
  • Roche
  • Contextual Genomics
  • GenMark Diagnostics
  • Hologic
  • Luminex Corporation
  • Binx Health
Segment by Type
  • Real-time PCR
  • Nested PCR with Melt Curve Analysis
  • PCR with Low density Microarray
  • PCR with Liquid Phase Bead Array
  • PCR with Electrochemical Detection
Segment by Application
  • Clinical Research Laboratory
  • Hospitals
  • Academic and Research Centers
  • Others
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East, Africa, and Latin America
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Multiplex Molecular Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Multiplex Molecular Diagnostic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Multiplex Molecular Diagnostic revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Multiplex Molecular Diagnostic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  1.2.2 Real-time PCR
  1.2.3 Nested PCR with Melt Curve Analysis
  1.2.4 PCR with Low density Microarray
  1.2.5 PCR with Liquid Phase Bead Array
  1.2.6 PCR with Electrochemical Detection
1.3 Market by Application
  1.3.1 Global Multiplex Molecular Diagnostic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  1.3.2 Clinical Research Laboratory
  1.3.3 Hospitals
  1.3.4 Academic and Research Centers
  1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Multiplex Molecular Diagnostic Market Perspective (2018-2029)
2.2 Global Multiplex Molecular Diagnostic Growth Trends by Region
  2.2.1 Multiplex Molecular Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Multiplex Molecular Diagnostic Historic Market Size by Region (2018-2023)
  2.2.3 Multiplex Molecular Diagnostic Forecasted Market Size by Region (2024-2029)
2.3 Multiplex Molecular Diagnostic Market Dynamics
  2.3.1 Multiplex Molecular Diagnostic Industry Trends
  2.3.2 Multiplex Molecular Diagnostic Market Drivers
  2.3.3 Multiplex Molecular Diagnostic Market Challenges
  2.3.4 Multiplex Molecular Diagnostic Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Revenue Multiplex Molecular Diagnostic by Players
  3.1.1 Global Multiplex Molecular Diagnostic Revenue by Players (2018-2023)
  3.1.2 Global Multiplex Molecular Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Multiplex Molecular Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Multiplex Molecular Diagnostic, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Multiplex Molecular Diagnostic Market Concentration Ratio
  3.4.1 Global Multiplex Molecular Diagnostic Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Multiplex Molecular Diagnostic Revenue in 2022
3.5 Global Key Players of Multiplex Molecular Diagnostic Head office and Area Served
3.6 Global Key Players of Multiplex Molecular Diagnostic, Product and Application
3.7 Global Key Players of Multiplex Molecular Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 MULTIPLEX MOLECULAR DIAGNOSTIC BREAKDOWN DATA BY TYPE

4.1 Global Multiplex Molecular Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Multiplex Molecular Diagnostic Forecasted Market Size by Type (2024-2029)

5 MULTIPLEX MOLECULAR DIAGNOSTIC BREAKDOWN DATA BY APPLICATION

5.1 Global Multiplex Molecular Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Multiplex Molecular Diagnostic Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Multiplex Molecular Diagnostic Market Size (2018-2029)
6.2 North America Multiplex Molecular Diagnostic Market Size by Type
  6.2.1 North America Multiplex Molecular Diagnostic Market Size by Type (2018-2023)
  6.2.2 North America Multiplex Molecular Diagnostic Market Size by Type (2024-2029)
  6.2.3 North America Multiplex Molecular Diagnostic Market Share by Type (2018-2029)
6.3 North America Multiplex Molecular Diagnostic Market Size by Application
  6.3.1 North America Multiplex Molecular Diagnostic Market Size by Application (2018-2023)
  6.3.2 North America Multiplex Molecular Diagnostic Market Size by Application (2024-2029)
  6.3.3 North America Multiplex Molecular Diagnostic Market Share by Application (2018-2029)
6.4 North America Multiplex Molecular Diagnostic Market Size by Country
  6.4.1 North America Multiplex Molecular Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
  6.4.2 North America Multiplex Molecular Diagnostic Market Size by Country (2018-2023)
  6.4.3 North America Multiplex Molecular Diagnostic Market Size by Country (2024-2029)
  6.4.4 United States
  6.4.5 Canada

7 EUROPE

7.1 Europe Multiplex Molecular Diagnostic Market Size (2018-2029)
7.2 Europe Multiplex Molecular Diagnostic Market Size by Type
  7.2.1 Europe Multiplex Molecular Diagnostic Market Size by Type (2018-2023)
  7.2.2 Europe Multiplex Molecular Diagnostic Market Size by Type (2024-2029)
  7.2.3 Europe Multiplex Molecular Diagnostic Market Share by Type (2018-2029)
7.3 Europe Multiplex Molecular Diagnostic Market Size by Application
  7.3.1 Europe Multiplex Molecular Diagnostic Market Size by Application (2018-2023)
  7.3.2 Europe Multiplex Molecular Diagnostic Market Size by Application (2024-2029)
  7.3.3 Europe Multiplex Molecular Diagnostic Market Share by Application (2018-2029)
7.4 Europe Multiplex Molecular Diagnostic Market Size by Country
  7.4.1 Europe Multiplex Molecular Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
  7.4.2 Europe Multiplex Molecular Diagnostic Market Size by Country (2018-2023)
  7.4.3 Europe Multiplex Molecular Diagnostic Market Size by Country (2024-2029)
  7.4.3 Germany
  7.4.4 France
  7.4.5 U.K.
  7.4.6 Italy
  7.4.7 Russia
  7.4.8 Nordic Countries

8 CHINA

8.1 China Multiplex Molecular Diagnostic Market Size (2018-2029)
8.2 China Multiplex Molecular Diagnostic Market Size by Type
  8.2.1 China Multiplex Molecular Diagnostic Market Size by Type (2018-2023)
  8.2.2 China Multiplex Molecular Diagnostic Market Size by Type (2024-2029)
  8.2.3 China Multiplex Molecular Diagnostic Market Share by Type (2018-2029)
8.3 China Multiplex Molecular Diagnostic Market Size by Application
  8.3.1 China Multiplex Molecular Diagnostic Market Size by Application (2018-2023)
  8.3.2 China Multiplex Molecular Diagnostic Market Size by Application (2024-2029)
  8.3.3 China Multiplex Molecular Diagnostic Market Share by Application (2018-2029)

9 ASIA (EXCLUDING CHINA)

9.1 Asia Multiplex Molecular Diagnostic Market Size (2018-2029)
9.2 Asia Multiplex Molecular Diagnostic Market Size by Type
  9.2.1 Asia Multiplex Molecular Diagnostic Market Size by Type (2018-2023)
  9.2.2 Asia Multiplex Molecular Diagnostic Market Size by Type (2024-2029)
  9.2.3 Asia Multiplex Molecular Diagnostic Market Share by Type (2018-2029)
9.3 Asia Multiplex Molecular Diagnostic Market Size by Application
  9.3.1 Asia Multiplex Molecular Diagnostic Market Size by Application (2018-2023)
  9.3.2 Asia Multiplex Molecular Diagnostic Market Size by Application (2024-2029)
  9.3.3 Asia Multiplex Molecular Diagnostic Market Share by Application (2018-2029)
9.4 Asia Multiplex Molecular Diagnostic Market Size by Region
  9.4.1 Asia Multiplex Molecular Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
  9.4.2 Asia Multiplex Molecular Diagnostic Market Size by Region (2018-2023)
  9.4.3 Asia Multiplex Molecular Diagnostic Market Size by Region (2024-2029)
  9.4.4 Japan
  9.4.5 South Korea
  9.4.6 China Taiwan
  9.4.7 Southeast Asia
  9.4.8 India
  9.4.9 Australia

10 MIDDLE EAST, AFRICA, AND LATIN AMERICA

10.1 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Type
  10.2.1 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Type (2018-2023)
  10.2.2 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Type (2024-2029)
  10.2.3 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Application
  10.3.1 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Application (2018-2023)
  10.3.2 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Application (2024-2029)
  10.3.3 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Country
  10.4.1 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
  10.4.2 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Country (2018-2023)
  10.4.3 Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Country (2024-2029)
  10.4.4 Brazil
  10.4.5 Mexico
  10.4.6 Turkey
  10.4.7 Saudi Arabia
  10.4.8 Israel
  10.4.9 GCC Countries

11 KEY PLAYERS PROFILES

11.1 BD
  11.1.1 BD Company Details
  11.1.2 BD Business Overview
  11.1.3 BD Multiplex Molecular Diagnostic Introduction
  11.1.4 BD Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.1.5 BD Recent Developments
11.2 bioMйrieux
  11.2.1 bioMйrieux Company Details
  11.2.2 bioMйrieux Business Overview
  11.2.3 bioMйrieux Multiplex Molecular Diagnostic Introduction
  11.2.4 bioMйrieux Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.2.5 bioMйrieux Recent Developments
11.3 SpeeDx
  11.3.1 SpeeDx Company Details
  11.3.2 SpeeDx Business Overview
  11.3.3 SpeeDx Multiplex Molecular Diagnostic Introduction
  11.3.4 SpeeDx Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.3.5 SpeeDx Recent Developments
11.4 Roche
  11.4.1 Roche Company Details
  11.4.2 Roche Business Overview
  11.4.3 Roche Multiplex Molecular Diagnostic Introduction
  11.4.4 Roche Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.4.5 Roche Recent Developments
11.5 Contextual Genomics
  11.5.1 Contextual Genomics Company Details
  11.5.2 Contextual Genomics Business Overview
  11.5.3 Contextual Genomics Multiplex Molecular Diagnostic Introduction
  11.5.4 Contextual Genomics Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.5.5 Contextual Genomics Recent Developments
11.6 GenMark Diagnostics
  11.6.1 GenMark Diagnostics Company Details
  11.6.2 GenMark Diagnostics Business Overview
  11.6.3 GenMark Diagnostics Multiplex Molecular Diagnostic Introduction
  11.6.4 GenMark Diagnostics Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.6.5 GenMark Diagnostics Recent Developments
11.7 Hologic
  11.7.1 Hologic Company Details
  11.7.2 Hologic Business Overview
  11.7.3 Hologic Multiplex Molecular Diagnostic Introduction
  11.7.4 Hologic Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.7.5 Hologic Recent Developments
11.8 Luminex Corporation
  11.8.1 Luminex Corporation Company Details
  11.8.2 Luminex Corporation Business Overview
  11.8.3 Luminex Corporation Multiplex Molecular Diagnostic Introduction
  11.8.4 Luminex Corporation Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.8.5 Luminex Corporation Recent Developments
11.9 Binx Health
  11.9.1 Binx Health Company Details
  11.9.2 Binx Health Business Overview
  11.9.3 Binx Health Multiplex Molecular Diagnostic Introduction
  11.9.4 Binx Health Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.9.5 Binx Health Recent Developments

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Multiplex Molecular Diagnostic Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Real-time PCR
Table 3. Key Players of Nested PCR with Melt Curve Analysis
Table 4. Key Players of PCR with Low density Microarray
Table 5. Key Players of PCR with Liquid Phase Bead Array
Table 6. Key Players of PCR with Electrochemical Detection
Table 7. Global Multiplex Molecular Diagnostic Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Multiplex Molecular Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Multiplex Molecular Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Multiplex Molecular Diagnostic Market Share by Region (2018-2023)
Table 11. Global Multiplex Molecular Diagnostic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Multiplex Molecular Diagnostic Market Share by Region (2024-2029)
Table 13. Multiplex Molecular Diagnostic Market Trends
Table 14. Multiplex Molecular Diagnostic Market Drivers
Table 15. Multiplex Molecular Diagnostic Market Challenges
Table 16. Multiplex Molecular Diagnostic Market Restraints
Table 17. Global Multiplex Molecular Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Multiplex Molecular Diagnostic Revenue Share by Players (2018-2023)
Table 19. Global Top Multiplex Molecular Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplex Molecular Diagnostic as of 2022)
Table 20. Global Multiplex Molecular Diagnostic Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Multiplex Molecular Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Multiplex Molecular Diagnostic, Headquarters and Area Served
Table 23. Global Key Players of Multiplex Molecular Diagnostic, Product and Application
Table 24. Global Key Players of Multiplex Molecular Diagnostic, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiplex Molecular Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Multiplex Molecular Diagnostic Revenue Market Share by Type (2018-2023)
Table 28. Global Multiplex Molecular Diagnostic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Multiplex Molecular Diagnostic Revenue Market Share by Type (2024-2029)
Table 30. Global Multiplex Molecular Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Multiplex Molecular Diagnostic Revenue Share by Application (2018-2023)
Table 32. Global Multiplex Molecular Diagnostic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Multiplex Molecular Diagnostic Revenue Share by Application (2024-2029)
Table 34. North America Multiplex Molecular Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Multiplex Molecular Diagnostic Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Multiplex Molecular Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Multiplex Molecular Diagnostic Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Multiplex Molecular Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Multiplex Molecular Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Multiplex Molecular Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Multiplex Molecular Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Multiplex Molecular Diagnostic Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Multiplex Molecular Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Multiplex Molecular Diagnostic Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Multiplex Molecular Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Multiplex Molecular Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Multiplex Molecular Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Multiplex Molecular Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Multiplex Molecular Diagnostic Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Multiplex Molecular Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Multiplex Molecular Diagnostic Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Multiplex Molecular Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Multiplex Molecular Diagnostic Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Multiplex Molecular Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Multiplex Molecular Diagnostic Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Multiplex Molecular Diagnostic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Multiplex Molecular Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Multiplex Molecular Diagnostic Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 66. BD Company Details
Table 67. BD Business Overview
Table 68. BD Multiplex Molecular Diagnostic Product
Table 69. BD Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 70. BD Recent Developments
Table 71. bioMйrieux Company Details
Table 72. bioMйrieux Business Overview
Table 73. bioMйrieux Multiplex Molecular Diagnostic Product
Table 74. bioMйrieux Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 75. bioMйrieux Recent Developments
Table 76. SpeeDx Company Details
Table 77. SpeeDx Business Overview
Table 78. SpeeDx Multiplex Molecular Diagnostic Product
Table 79. SpeeDx Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 80. SpeeDx Recent Developments
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Multiplex Molecular Diagnostic Product
Table 84. Roche Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 85. Roche Recent Developments
Table 86. Contextual Genomics Company Details
Table 87. Contextual Genomics Business Overview
Table 88. Contextual Genomics Multiplex Molecular Diagnostic Product
Table 89. Contextual Genomics Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 90. Contextual Genomics Recent Developments
Table 91. GenMark Diagnostics Company Details
Table 92. GenMark Diagnostics Business Overview
Table 93. GenMark Diagnostics Multiplex Molecular Diagnostic Product
Table 94. GenMark Diagnostics Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 95. GenMark Diagnostics Recent Developments
Table 96. Hologic Company Details
Table 97. Hologic Business Overview
Table 98. Hologic Multiplex Molecular Diagnostic Product
Table 99. Hologic Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 100. Hologic Recent Developments
Table 101. Luminex Corporation Company Details
Table 102. Luminex Corporation Business Overview
Table 103. Luminex Corporation Multiplex Molecular Diagnostic Product
Table 104. Luminex Corporation Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 105. Luminex Corporation Recent Developments
Table 106. Binx Health Company Details
Table 107. Binx Health Business Overview
Table 108. Binx Health Multiplex Molecular Diagnostic Product
Table 109. Binx Health Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 110. Binx Health Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Multiplex Molecular Diagnostic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Multiplex Molecular Diagnostic Market Share by Type: 2022 VS 2029
Figure 3. Real-time PCR Features
Figure 4. Nested PCR with Melt Curve Analysis Features
Figure 5. PCR with Low density Microarray Features
Figure 6. PCR with Liquid Phase Bead Array Features
Figure 7. PCR with Electrochemical Detection Features
Figure 8. Global Multiplex Molecular Diagnostic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Multiplex Molecular Diagnostic Market Share by Application: 2022 VS 2029
Figure 10. Clinical Research Laboratory Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Academic and Research Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Multiplex Molecular Diagnostic Report Years Considered
Figure 15. Global Multiplex Molecular Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Multiplex Molecular Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Multiplex Molecular Diagnostic Market Share by Region: 2022 VS 2029
Figure 18. Global Multiplex Molecular Diagnostic Market Share by Players in 2022
Figure 19. Global Top Multiplex Molecular Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplex Molecular Diagnostic as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Multiplex Molecular Diagnostic Revenue in 2022
Figure 21. North America Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Multiplex Molecular Diagnostic Market Share by Type (2018-2029)
Figure 23. North America Multiplex Molecular Diagnostic Market Share by Application (2018-2029)
Figure 24. North America Multiplex Molecular Diagnostic Market Share by Country (2018-2029)
Figure 25. United States Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Multiplex Molecular Diagnostic Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Multiplex Molecular Diagnostic Market Share by Type (2018-2029)
Figure 29. Europe Multiplex Molecular Diagnostic Market Share by Application (2018-2029)
Figure 30. Europe Multiplex Molecular Diagnostic Market Share by Country (2018-2029)
Figure 31. Germany Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Multiplex Molecular Diagnostic Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Multiplex Molecular Diagnostic Market Share by Type (2018-2029)
Figure 39. China Multiplex Molecular Diagnostic Market Share by Application (2018-2029)
Figure 40. Asia Multiplex Molecular Diagnostic Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Multiplex Molecular Diagnostic Market Share by Type (2018-2029)
Figure 42. Asia Multiplex Molecular Diagnostic Market Share by Application (2018-2029)
Figure 43. Asia Multiplex Molecular Diagnostic Market Share by Region (2018-2029)
Figure 44. Japan Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Multiplex Molecular Diagnostic Market Share by Country (2018-2029)
Figure 54. Brazil Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. BD Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 61. bioMйrieux Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 62. SpeeDx Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 63. Roche Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 64. Contextual Genomics Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 65. GenMark Diagnostics Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 66. Hologic Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 67. Luminex Corporation Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 68. Binx Health Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


More Publications